Selasa, 26 Juni 2012

Smartphone App Improves Ovarian Tumor Database

Smartphone App Improves Ovarian Tumor Database

Featured Article
Main Category: Ovarian Cancer
Also Included In: IT / Internet / E-mail;  Medical Devices / Diagnostics
Article Date: 26 Jun 2012 - 4:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions   <!-- rate icon rate article Advertisement


Patient / Public:not yet rated

Healthcare Prof:not yet rated


When surgeons complete an operation, they often have to go away and immediately fill in records to upload to databases for programs that are tracking patient and disease outcomes to help current and future research and inform treatment decisions. Now thanks to a new smartphone app, ovarian cancer surgeons in British Columbia in Canada can enter and upload tumor data directly from the operating theatre.

"As soon as the case is finished, I can pick up my iPhone and enter all of the vital information from the procedure we just performed," gynaecological surgeon Dr Sarah Finlayson, who is an assistant professor in the University of British Columbia (UBC) Faculty of Medicine, told the press on Monday.

The data is uploaded to a provincial database that stores tumor information for the Cheryl Brown Ovarian Cancer Outcomes Unit, which developed the smartphone app. The information supports current and future studies into ovarian cancer.

The Outcomes Unit is a division of the Ovarian Cancer Research Program (OvCaRe) at the BC Cancer Agency and Vancouver Coastal Health.

Finlayson, who is also a researcher with OvCaRe, championed the idea of a smartphone app to improve the database.

The app prompts surgeons to enter specific surgical details, which then upload directly into the Outcomes Unit database, saving time and increasing accuracy.

Patient anonymity is assured via unique patient IDs and coding that scrambles them as the data is sent. The critical data, approved and anonymized, is then immediately available for leading edge ovarian researchers to use.

Finalyson said it "takes approximately five minutes to complete versus a lengthy chart review process, which would then need to be manually entered into the system".

The innovation has been made possible thanks to a generous donation from Doug Gray a supporter of OvCaRe , and whose wife is an ovarian cancer survivor.

"My wife, Diana, was diagnosed with a rare sub-type of ovarian cancer, ovarian clear cell carcinoma (OCCC), in May of 2008. She has been in remission for three and a half years since she completed her surgery and chemotherapy and lives a full life," said Gray.

Gray said he was keen to support a "sophisticated clinical database project" for the BC Cancer Foundation.

"I saw this project as an opportunity to augment clinical research knowledge of ovarian cancer that could benefit patients and possibly my wife going forward," he explained.

The new app is part of a suite of upgrades to the Outcomes Unit, which aims not only to provide high quality information for research, but also make it available to improve clinical care of patients.

Eventually entire health teams will be able to enter customized patient data that can then be extracted and analyzed in "real time" for clinical treatment.

Breakthroughs in ovarian cancer research rely on gaining new insights into the biology of the disease, and how patients respond to treatment. High quality data gathered in hospitals and clinics underpin this process. Recently, this type of data has helped a number of research projects, including a landmark study that identified ovarian cancer subtypes.

Over the past 25 years, the Cheryl Brown Ovarian Cancer Outcomes Unit has recorded data on approximately 3,400 ovarian tumors and has contributed to over 40 research projects.

Ovarian cancer is the most serious of all gynecological cancers. Most ovarian cancers are either ovarian epithelial carcinomas (cancer that starts in the cells on the surface of the ovary) or malignant germ cell tumors (cancer that starts inside egg cells).

According to Ovarian Cancer Canada, over 2,600 Canadian women are diagnosed with the disease every year, and every year 1,750 women die from it. There is no screening test and symptoms can be vague, varied and easily missed. But when found early, the survival rate is 90%.

Written by Catharine Paddock
Copyright: Medical News Today
Not to be reproduced without permission of Medical News Today

Please use one of the following formats to cite this article in your essay, paper or report:

MLA


APA

Please note: If no author information is provided, the source is cited instead.



Add Your Opinion On This Article

'Smartphone App Improves Ovarian Tumor Database'

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



MediLexicon International Ltd Logo

Privacy Policy | Terms and Conditions

MediLexicon International Ltd
Bexhill-on-Sea, United Kingdom
MediLexicon International Ltd © 2004-2012 All rights reserved.
MNT (logo) is the registered EU trade mark of MediLexicon Int. Limited.

Everyday Health Network back to top | home | privacy policy

MediLexicon International Ltd Logo MediLexicon International Ltd
Bexhill-on-Sea, United Kingdom
MediLexicon International Ltd © 2004-2012 All rights reserved.
MNT (logo) is the registered EU trade mark of MediLexicon Int. Limited.

Tidak ada komentar:

Posting Komentar